CAS: 2102933-95-7
Ref: AN-AG01EO5W
| 1mg | 65.00 € | |
| 2mg | 97.00 € | |
| 5mg | 172.00 € | |
| 10mg | 188.00 € | |
| 25mg | 504.00 € | |
| 50mg | 592.00 € | |
| 100mg | To inquire | |
| 500mg | To inquire |
Estimated delivery in United States, on Monday 3 Jun 2024
GSK-LSD1 dihydrochloride
CAS:2102933-95-7
GSK-LSD1 dihydrochloride (GSK-LSD1 2HCl) is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity …
Formula:
C14H22Cl2N2
Purity:
100%
Color and Shape:
Solid
Molecular weight:
289.24
Ref: TM-T2315
| 1mg | 40.00 € | |
| 2mg | 52.00 € | |
| 5mg | 70.00 € | |
| 10mg | 101.00 € | |
| 25mg | 206.00 € | |
| 50mg | 312.00 € | |
| 100mg | 513.00 € | |
| 500mg | 1,093.00 € | |
| 1ml*10 (DMSO) | 70.00 € |
Estimated delivery in United States, on Monday 10 Jun 2024
GSK LSD1 Dihydrochloride
Controlled ProductCAS:2102933-95-7
Applications GSK LSD1 Dihydrochloride is an irreversible mechanism-based inhibitor of LSD1. Lysine-specific demthylase 1 (LSD1) …
Formula:
C14H22Cl2N2
Color and Shape:
Neat
Molecular weight:
342.407
Ref: TR-G797570
| 100mg | 2,172.00 € |
Estimated delivery in United States, on Friday 12 Jul 2024
GSK-LSD1 dihydrochloride
CAS:2102933-95-7
GSK-LSD1 is a potential drug for the treatment of cervical cancer and myeloid leukemia. GSK-LSD1 …
Formula:
C14H22Cl2N2
Purity:
Min. 95%
Molecular weight:
289.24 g/mol
Ref: 3D-CJD93395
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 15 Jul 2024
